Saudi Arabia Blood Glucose Test Strip Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Saudi Arabia Blood Glucose Test Strip Market Segmentation, By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films, and Optical Strips), Technology (Glucose Oxidase and Glucose Dehydrogenase), Modality (Use and Throw and Built-In Indicator), Pricing (Standard and Premium), Sample (Whole Blood and Plasma), Mode Of Purchase (Over The Counter and Prescription Based), Packaging (50 Strips, 100 Strips, and 25 Strips), Age Group (Adult, Geriatric, and Pediatric), Application (Type 2 Diabetes, Type 1 Diabetes, Pre-Diabetes, and Gestational Diabetes), End User (Home Healthcare, Hospital, Diagnostic Laboratory, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others) - Industry Trends and Forecast to 2032

Saudi Arabia Blood Glucose Test Strip Market Size

• The Saudi Arabia blood glucose test strip market size was valued at USD 138.78 million in 2024 and is expected to reach USD 187.02 million by 2032, at a CAGR of 3.80% during the forecast period
• The market growth is largely driven by the increasing prevalence of diabetes in the Kingdom, coupled with greater public health awareness and government-led screening initiatives, which are enhancing early detection and self-monitoring among patients
• Furthermore, rising consumer demand for accessible, accurate, and easy-to-use diagnostic tools is reinforcing blood glucose test strips as an essential component of diabetes care. These combined drivers are fueling sustained demand and innovation in the market, positioning test strips as a cornerstone of Saudi Arabia’s diabetes management strategy

Saudi Arabia Blood Glucose Test Strip Market Analysis

• Blood glucose test strips, essential for real-time blood sugar monitoring, are increasingly relied upon for effective diabetes management due to their portability, ease of use, and compatibility with a wide range of glucometers
• The growing demand for blood glucose test strips is primarily driven by the rising incidence of diabetes, increased public awareness regarding self-monitoring, and strong governmental support for non-communicable disease management programs
• Significant factors contributing to market growth include rising healthcare expenditure, increased availability of diabetes management products through retail pharmacies, and expanded insurance coverage that supports access to self-monitoring supplies
• The integration of digital health platforms with glucometer data and growing consumer preference for OTC purchase options are further accelerating market expansion, especially among tech-savvy and health-conscious individuals
• The Type 2 Diabetes application segment dominated the Saudi Arabia blood glucose test strip market with the largest revenue share of 72.6% in 2024, as this patient group requires frequent monitoring for effective disease control and treatment optimization

Report Scope and Saudi Arabia Blood Glucose Test Strip Market Segmentation

Saudi Arabia Blood Glucose Test Strip Market Trends

Advancement in Connectivity and Personalized Diabetes Management

• A significant and accelerating trend in the Saudi Arabia blood glucose test strip market is the growing integration of test strips with connected glucometers and digital health platforms, enabling personalized diabetes care and better glycemic control. This shift is enhancing user engagement, compliance, and overall disease management outcomes
• For instance, modern glucometers from brands such as Accu-Chek and FreeStyle now sync with mobile applications, allowing patients to track their glucose levels over time, receive insights, and share data remotely with healthcare professionals. This real-time connectivity is transforming how patients manage their condition and interact with caregivers
• The integration of cloud-based platforms and Bluetooth-enabled meters allows seamless transmission of readings, trend analysis, and even automated alerts in cases of hypo- or hyperglycemia, making blood glucose monitoring a more proactive and responsive process
• These innovations align with Saudi Arabia's Vision 2030 goals to digitize healthcare and promote preventive care, thereby driving demand for smart, connected diabetes monitoring solutions that go beyond simple readings
• In addition, several test strips are being designed with improved enzyme stability and faster response times, catering to the hot climate conditions and accuracy demands of the region. Local adaptations such as temperature-resistant packaging and minimal sample volume requirements are gaining traction
• As consumers become more digitally aware and health-conscious, the demand for connected, user-friendly, and data-enabled test strips is growing rapidly across both individual and clinical use segments, driving manufacturers to offer more integrated and intelligent glucose monitoring tools

Saudi Arabia Blood Glucose Test Strip Market Dynamics

Driver

Rising Diabetes Prevalence and Government Focus on Preventive Healthcare

• The surging prevalence of diabetes in Saudi Arabia currently among the highest globally—is a key driver for the growing demand for blood glucose test strips. An increasingly sedentary lifestyle, rising obesity rates, and genetic predisposition are contributing to this public health burden
• For instance, national health programs such as the Saudi National Diabetes Registry and increased government spending on non-communicable diseases are expanding early screening and long-term monitoring efforts, which in turn fuel the consumption of test strips
• As more patients are diagnosed, and health authorities emphasize regular monitoring to prevent complications, blood glucose test strips have become essential diagnostic tools. Their use is encouraged both in clinical settings and at home, especially for patients managing their glucose levels independently
• In addition, health awareness campaigns and educational initiatives by both public and private stakeholders are promoting self-monitoring practices, empowering patients to adopt proactive diabetes management
• The increasing availability of test strips through pharmacies, insurance-backed reimbursement models, and tech-integrated monitoring kits is further contributing to market expansion in the Kingdom

Restraint/Challenge

Affordability and Reimbursement Gaps for Uninsured Populations

• A significant challenge facing the Saudi Arabia blood glucose test strip market is the cost burden for uninsured or underinsured populations. While many strips are covered under government healthcare services, not all patients have equal access to reimbursed monitoring supplies
• For instance, expatriate workers and lower-income segments who may not be enrolled in public insurance programs often face out-of-pocket costs, which can discourage regular testing and compromise long-term diabetes management
• Moreover, fluctuations in pricing due to import dependencies and brand preference for premium strips can limit accessibility, especially for families managing multiple diabetic members. This is further complicated by the need for consistent usage, as frequent testing is required for effective disease control
• Addressing this affordability gap through greater local manufacturing, expanding public-private insurance coverage, and promoting cost-effective generic alternatives will be essential to ensure broader access and compliance
• In addition, some users may lack awareness about the importance of frequent glucose testing, highlighting the need for continued education on the long-term health and cost benefits of routine monitoring, particularly in underserved communities

Saudi Arabia Blood Glucose Test Strip Market Scope

The market is segmented on the basis of type, technology, modality, pricing, sample, mode of purchase, packaging, age group, application, end user, and distribution channel.

• By Type

On the basis of type, the Saudi Arabia blood glucose test strip market is segmented into thick film electrochemical films, thin film electrochemical films, and optical strips. The thick film electrochemical films segment dominated the market with the largest revenue share of 46.7% in 2024, due to its affordability, reliability, and compatibility with widely used glucometers. These strips are widely adopted across both home and clinical settings, supported by their long shelf life and stable enzyme activity.

The optical strips segment is anticipated to witness the fastest growth rate from 2025 to 2032, driven by increasing interest in non-invasive and innovative glucose detection technologies. Their potential to improve user comfort and accuracy is gaining attention from technology-focused users and healthcare providers.

• By Technology

On the basis of technology, the Saudi Arabia blood glucose test strip market is segmented into glucose oxidase and glucose dehydrogenase. The glucose oxidase segment held the largest market revenue share in 2024, accounting for 54.3%, due to its high glucose specificity, cost-effectiveness, and long-standing use in commercial blood glucose test strips.

The glucose dehydrogenase segment is expected to witness the fastest growth during the forecast period, owing to its compatibility with varying oxygen levels and suitability for alternative sample types, making it a preferred choice for advanced meter designs.

• By Modality

On the basis of modality, the Saudi Arabia blood glucose test strip market is segmented into use and throw and built-in indicator. The use and throw segment dominated the market with the largest market share of 71.5% in 2024, supported by high consumer preference for hygienic and convenient single-use products. These strips are cost-effective and reduce the risk of contamination.

The built-in indicator segment is projected to grow rapidly from 2025 to 2032, due to increasing demand for intuitive strips that confirm sufficient sample application, reducing user error and improving test reliability.

• By Pricing

On the basis of pricing, the Saudi Arabia blood glucose test strip market is segmented into standard and premium. The standard segment held the largest market share of 68.9% in 2024, driven by affordability and wider adoption among patients who perform frequent testing. These strips are accessible through retail outlets and are often supported by public insurance programs.

The premium segment is expected to grow at a steady pace during forecast period, driven by the demand for enhanced features such as faster response times, smaller blood sample requirements, and compatibility with digital health apps.

• By Sample

On the basis of sample type, the Saudi Arabia blood glucose test strip market is segmented into whole blood and plasma. The whole blood segment dominated the market with the largest market share of 84.2% in 2024, due to its widespread use in home glucometers and compatibility with standard testing protocols.

The plasma segment is expected to witness fastest growth during forecast period, particularly in clinical settings where higher accuracy and lab-grade analysis are prioritized.

• By Mode of Purchase

On the basis of mode of purchase, the Saudi Arabia blood glucose test strip market is segmented into over the counter (OTC) and prescription-based. The over the counter segment accounted for the largest revenue share of 61.4% in 2024, owing to the convenience of purchasing directly from retail pharmacies without the need for a prescription.

The prescription-based segment is projected to grow at fastest rate during forecast period, supported by insurance-driven purchases and physician-supervised diabetes care programs.

• By Packaging

On the basis of packaging, the Saudi Arabia blood glucose test strip market is segmented into 50 strips, 100 strips, and 25 strips. The 50 strips segment held the largest market share of 58.6% in 2024, due to its affordability and practicality for routine testers. It balances cost and usage frequency, making it the preferred choice for both new and experienced users.

The 100 strips segment is anticipated to grow rapidly during forecast period, especially among high-frequency users and institutional buyers such as hospitals and diagnostic labs.

• By Age Group

On the basis of age group, the Saudi Arabia blood glucose test strip market is segmented into adult, geriatric, and pediatric. The adult segment dominated the market with the largest share of 66.7% in 2024, due to the high prevalence of type 2 diabetes in the adult population and their growing adoption of self-monitoring devices.

The geriatric segment is projected to show strong growth during the forecast period, attributed to the increased risk of diabetes and related complications in aging individuals, along with improved access to at-home care solutions.

• By Application

On the basis of application, the Saudi Arabia blood glucose test strip market is segmented into type 2 diabetes, type 1 diabetes, pre-diabetes, and gestational diabetes. The type 2 diabetes segment held the largest market share of 72.6% in 2024, as this population group requires frequent monitoring to control blood glucose levels and manage medication regimens effectively.

The gestational diabetes segment is expected to see increasing demand during forecast period, as prenatal screening and maternal health initiatives expand across Saudi Arabia.

• By End User

On the basis of end user, the Saudi Arabia blood glucose test strip market is segmented into home healthcare, hospital, diagnostic laboratory, and others. The home healthcare segment led the market with the largest market share of 64.8% in 2024, driven by the growing trend of self-monitoring and rising patient empowerment in diabetes management.

The hospital segment continues to grow at fastest rate during forecast period, particularly for newly diagnosed patients and those requiring intensive monitoring during inpatient care.

• By Distribution Channel

On the basis of distribution channel, the Saudi Arabia blood glucose test strip market is segmented into retail sales, direct tender, and others. The retail sales segment dominated the market with the largest market revenue share of 59.2% in 2024, owing to the widespread presence of pharmacies and consumer preference for convenient access to testing supplies.

The direct tender segment is expected to grow at fastest rate during forecast period, particularly in the public healthcare sector, where government contracts facilitate bulk procurement for hospitals and clinics.

Saudi Arabia Blood Glucose Test Strip Market Share

The Saudi Arabia blood glucose test strip industry is primarily led by well-established companies, including:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Abbott (U.S.)
• Ascensia Diabetes Care Holdings AG (Switzerland)
• LifeScan, Inc. (U.S.)
• ARKRAY, Inc. (Japan)
• B. Braun SE (Germany)
• Bionime Corporation (Taiwan)
• AgaMatrix, Inc. (U.S.)
• i-SENS, Inc. (South Korea)
• Sinocare Inc. (China)
• Nipro Corporation (Japan)
• Trividia Health, Inc. (U.S.)
• Ypsomed AG (Switzerland)
• Terumo Corporation (Japan)
• 77 Elektronika Kft. (Hungary)
• TaiDoc Technology Corporation (Taiwan)
• Beurer GmbH (Germany)
• Dexcom, Inc. (U.S.)
• Nova Biomedical Corporation (U.S.)
• OK Biotech Co., Ltd. (Taiwan)

What are the Recent Developments in Saudi Arabia Blood Glucose Test Strip Market?

• In June 2024, Roche Diabetes Care expanded its presence in Saudi Arabia by launching a localized awareness campaign promoting self-monitoring of blood glucose using its Accu-Chek line of test strips and meters. The initiative, aligned with Vision 2030’s health sector transformation goals, emphasizes the importance of early detection and continuous glucose monitoring in managing diabetes, particularly among newly diagnosed patients. This campaign demonstrates Roche’s commitment to patient education and expanding access to reliable testing solutions in the Kingdom
• In May 2024, Abbott Laboratories partnered with a network of private healthcare providers across major cities such as Riyadh and Jeddah to offer subsidized access to FreeStyle glucose monitoring systems, including compatible blood glucose test strips. The program aims to support low-income diabetic patients through discounted pricing and free educational resources, showcasing Abbott’s strategy to address affordability barriers while strengthening its market share in Saudi Arabia’s competitive diabetes care segment
• In April 2024, the Saudi Food and Drug Authority (SFDA) announced a fast-track regulatory pathway for essential diagnostic supplies, including blood glucose test strips, to improve availability and shorten import timelines. This policy update is expected to benefit global and regional manufacturers by expediting product registration and reducing supply chain delays. The move reflects the government’s intent to improve access to chronic disease management tools and ensure uninterrupted care for diabetic patients
• In March 2024, Bionime Corporation, a Taiwan-based diagnostics company, collaborated with local distributor MedTech Arabia to launch its GM700S smart glucose meter and test strips in Saudi Arabia. The product, tailored for hot climates and Arabic-language interface support, is designed to improve user compliance through smartphone integration and Bluetooth connectivity. This development underscores growing demand for connected, user-friendly diabetes monitoring solutions in the Kingdom
• In January 2024, the Ministry of Health, in collaboration with several regional hospitals, introduced a mobile diabetes screening initiative targeting underserved rural areas in northern and eastern Saudi Arabia. The program uses portable glucometers and blood glucose test strips to offer on-site testing and diagnosis, aiming to reduce undiagnosed diabetes cases and provide immediate care referrals. This initiative highlights the government's proactive approach in expanding diagnostic access and promoting early intervention

SKU-70671